#bispecific adcs

Discover 2 curated intelligence briefings related to this specific topic.

Biological Clocks: The Mortality Math of 2026
Science & Nature

Biological Clocks: The Mortality Math of 2026

2026 signals a hard break from chronological age as the primary health marker. 321,324 participants in recent cohorts prove that biological acceleration is the only metric that matters for heart disease.

Read Analysis
Next-Gen Ligation Dictates ADC Industrial Viability
Science & Nature

Next-Gen Ligation Dictates ADC Industrial Viability

Industrial scale-up of Antibody-Drug Conjugates (ADCs) now demands a transition from random conjugation to site-specific bioorthogonal ligation. By integrating high-yield protein secretion platforms and multifunctional payloads like STING antagonists, manufacturers can stabilize the drug-to-antibody ratio (DAR) for complex bispecific architectures.

Read Analysis